Christopher Gibson, CEO: Recursion Pharmaceuticals RXRX Sell · Filed 23/03/10

Trade details

Type: Insider sale
Amount: $574,209
Shares · price: 70,890 sh · $8.10 a share
Held after: 963,787 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Christopher GibsonCEO
Trade date: 23/03/08
Filed: 23/03/10
Days to filing: 2 days

Sold 6.9% of holdings

Share of holding sold: 6.9%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/02/06~23/04/07

Christopher Gibson's recent trades

Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$262K
77,290 sh
$262K
Filed 08/21
Traded 08/21
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$255K
75,000 sh
$255K
Filed 08/20
Traded 08/20
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$327.5K
100,000 sh
$327.5K
Filed 08/19
Traded 08/19
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$80.4K
26,806 sh
$80.4K
Filed 08/18
Traded 08/18
Christopher GibsonDirector
Planned saleRecursion Pharmaceuticals
Planned sale
Recursion Pharmaceuticals
RXRX
$331K
100,000 sh
$331K
Filed 08/13
Traded 08/13

Christopher Gibson, CEO — sold $574.2K of Recursion Pharmaceuticals RXRX · 6.9% of holdings | Whalegun